Question 1

What is KPV?

Accepted Answer

KPV is a tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It retains the potent anti-inflammatory properties of alpha-MSH without the pigmentation (tanning) side effects, making it a focused anti-inflammatory research compound.

Question 2

What are the research benefits of KPV?

Accepted Answer

Research on KPV has investigated its potential effects in several areas, including: Potent anti-inflammatory without tanning side effects; Studied for inflammatory bowel conditions (colitis, IBD); Researched for skin inflammation and wound healing; Multiple administration routes (oral, SubQ, topical). These findings are primarily from preclinical and animal studies unless otherwise noted. Results may not translate directly to humans.

Question 3

How does KPV work?

Accepted Answer

KPV enters cells and travels to the nucleus where it interacts with inflammatory signaling pathways. It inhibits NF-kB activation, one of the master regulators of inflammation, reducing the production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta. Unlike full-length alpha-MSH, KPV does not significantly activate melanocortin receptors responsible for pigmentation.

Question 4

What is the FDA/legal status of KPV?

Accepted Answer

KPV is not currently FDA-approved for human therapeutic use. It is classified as a research compound and is available for research use only. It has not been evaluated for safety or efficacy in humans by regulatory agencies. Always consult applicable laws in your jurisdiction before purchase or use.

Question 5

What are the known risks or side effects of KPV?

Accepted Answer

Based on available research, KPV has been associated with the following in study settings: Generally well-tolerated in available research; Mild GI discomfort with oral administration; Injection site reactions with SubQ; Limited human clinical trial data. Long-term safety data in humans is limited or absent for most research peptides. This should not be taken as a complete safety profile.

Question 6

Where can I find published research on KPV?

Accepted Answer

Published research on KPV can be found on PubMed (pubmed.ncbi.nlm.nih.gov). Search for "KPV" or its aliases (Lys-Pro-Val, alpha-MSH fragment) to find peer-reviewed studies. PEP.WIKI aggregates key studies with abstracts and study type classifications on each compound's research page.

KPV

Overview

Mechanism of Action

Key Research Benefits

Clinical Evidence Summary

Key Studies / PubMed References

NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.

Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.

Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.

KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.

Vimentin is required for tumor progression and metastasis in a mouse model of non-small cell lung cancer.

Side Effects & Safety

Known Interactions

Frequently Asked Questions

Research Disclaimer